Begin main content

Reports

We found 4944 result(s)

letermovir (Prevymis)

Last Updated: January 18, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: letermovir
Indications: Cytomegalovirus infection, prophylaxis

  • Brand Name: Prevymis
  • Manufacturer: Merck Canada Inc.
  • Project Number: SR0545-000
  • Project Status: Active
  • Submission Type: New

Tags

Infectious Diseases, HIV/AIDS, Infectious diseases

dexamethasone (Ozurdex)

Last Updated: January 18, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: dexamethasone
Indications: Diabetic macular edema

  • Brand Name: Ozurdex
  • Manufacturer: Allergan Inc.
  • Project Number: SR0535-000
  • Project Status: Active
  • Submission Type: NewIndication

Tags

Eye, Dexamethasone, Diabetic Retinopathy, Diabetes, Ozurdex; DME; diabetic macular edema; diabetic macular oedema

fluticasone propionate / salmeterol xinafoate (TBC)

Last Updated: January 4, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: fluticasone propionate / salmeterol xinafoate
Indications: Asthma

  • Brand Name: TBC
  • Manufacturer: TEVA Canada Innovation
  • Project Number: SR0540-000
  • Project Status: Received
  • Submission Type: NewCombination

latanoprost (Monoprost )

Last Updated: January 18, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: latanoprost
Indications: glaucoma and ocular hypertension

  • Brand Name: Monoprost
  • Manufacturer: Laboratoires Théa
  • Project Number: SR0541-000
  • Project Status: Active
  • Submission Type: New

Tags

Eye

tenofovir alafenamide (Vemlidy)

Last Updated: January 16, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: tenofovir alafenamide
Indications: Hepatitis B, chronic

  • Brand Name: Vemlidy
  • Manufacturer: Gilead Sciences Canada, Inc.
  • Project Number: SR0537-000
  • Project Status: Active
  • Submission Type: New

Tags

Hepatitis, Infectious Diseases, Hepatitis, Infectious diseases

tocilizumab (Actemra )

Last Updated: January 17, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: tocilizumab
Indications: Giant cell arteritis (GCA)

  • Brand Name: Actemra
  • Manufacturer: Hoffmann-La Roche Limited
  • Project Number: SR0534-000
  • Project Status: Active
  • Submission Type: NewIndication

Tags

Nervous System, Giant Cell Arteritis, Cardiovascular, Nervous system, giant cell arteritis

nitisinone (MDK-Nitisinone)

Last Updated: January 10, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: nitisinone
Indications: Hereditary tyrosinemia type 1

  • Brand Name: MDK-Nitisinone
  • Manufacturer: MendeliKABS Inc
  • Project Number: SR0538-000
  • Project Status: Active

Tags

Digestive System, Genetics, Pediatrics, Tyrosinemias, Digestive system, Genetics, Pediatrics, nitisinone; tyrosinemia

fluticasone propionate (Aermony RespiClick)

Last Updated: January 4, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: fluticasone propionate
Indications: Asthma

  • Brand Name: Aermony RespiClick
  • Manufacturer: TEVA Canada Innovation
  • Project Number: SR0539-000
  • Project Status: Active
  • Submission Type: New

Tags

Asthma, Asthma, Respiratory

nusinersen (Spinraza)

Last Updated: January 12, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: nusinersen
Indications: Spinal Muscular Atrophy

  • Brand Name: Spinraza
  • Manufacturer: Biogen Canada Inc.
  • Project Number: SR0525-000
  • Project Status: Active
  • Submission Type: New

Tags

Muscular Atrophy, Spinal, Spinal Muscular Atrophies of Childhood, Parkinson, Spinraza; nusinersen; spinal muscular atrophy; spinal amyotrophy

cysteamine bitartrate (Procysbi)

Last Updated: January 18, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: cysteamine bitartrate
Indications: Nephropathic cystinosis

  • Brand Name: Procysbi
  • Manufacturer: Horizon Pharma
  • Project Number: SR0526-000
  • Project Status: Active
  • Submission Type: New

Tags

Genetics, Pediatrics, Cysteamine, Cystinosis, Delayed-Action Preparations, Genetics, Pediatrics, Procysbi; cysteamine bitartrate; cystinosis; delayed release; sustained release; extended release; nephropathic; delayed action; controlled release; time release